A detailed history of Vident Advisory, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Vident Advisory, LLC holds 2,128 shares of JAZZ stock, worth $271,830. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,128
Previous 124,259 98.29%
Holding current value
$271,830
Previous $15 Billion 98.48%
% of portfolio
0.01%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $12.7 Million - $14.5 Million
-122,131 Reduced 98.29%
2,128 $227 Million
Q1 2024

May 14, 2024

BUY
$115.19 - $132.77 $4.07 Million - $4.69 Million
35,347 Added 39.76%
124,259 $15 Billion
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $9.91 Million - $11.8 Million
86,702 Added 3923.17%
88,912 $10.9 Billion
Q3 2023

Feb 21, 2024

SELL
$122.0 - $145.31 $10.6 Million - $12.6 Million
-86,702 Reduced 97.51%
2,210 $286 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $269,620 - $321,135
2,210 New
2,210 $286 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.01B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.